3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
35
HER2-positive Breast Cancer
3
Brain Neoplasms
3
Neoplasm Metastasis
2
Endometrial Neoplasms
2
Breast Diseases
2
Anatomic Stage II Breast Cancer AJCC v8
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Solid Tumors
1
Solid Cancer
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Multiple Myeloma
1
Motor Activity
1
Metastatic Breast Cancer With a Isolated Brain Progression
1
Meningeal Neoplasms
1
Meningeal Carcinomatosis
1
Melanoma
1
Malignant Solid Neoplasm
1
Lymphoma
1
Lung Neoplasms
1
Invasive Breast Cancer
1
Inflammatory Breast Neoplasms
1
Hematologic Neoplasms
1
Interventions
tucatinib
1
pertuzumab
1
Trastuzumab
1
Biosimilar Pharmaceuticals
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Metastatic Breast Cancer With a Isolated Brain Progression
×
pertuzumab
×
Clear all
NCT05041842
2025-11-17
InTTercePT
UNICANCER
Phase 2
Active not recruiting
53 enrolled